Sri Padmavathi Breeding Farms Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 18-12-2024
- Paid Up Capital ₹ 2.00 Cr
as on 18-12-2024
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.80 Cr
as on 18-12-2024
- Revenue 17.91%
(FY 2019)
- Profit 115.22%
(FY 2019)
- Ebitda -17.63%
(FY 2019)
- Net Worth 0.20%
(FY 2019)
- Total Assets -1.89%
(FY 2019)
About Sri Padmavathi Breeding Farms
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹5.80 Cr.
Vijay Godala and Bollam Reddy serve as directors at the Company.
- CIN/LLPIN
U01222TG2012PTC081084
- Company No.
081084
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 May 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sri Padmavathi Breeding Farms?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bollam Reddy  | Director | 23-May-2012 | Current |
| Vijay Godala | Director | 23-May-2012 | Current |
Financial Performance of Sri Padmavathi Breeding Farms.
Sri Padmavathi Breeding Farms Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 17.91% increase. The company also saw a substantial improvement in profitability, with a 115.22% increase in profit. The company's net worth moved up by a moderate rise of 0.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Padmavathi Breeding Farms?
In 2019, Sri Padmavathi Breeding Farms had a promoter holding of 55.00% and a public holding of 45.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Parvy Pharma Private LimitedActive 29 years 6 months
Vijay Godala and Bollam Reddy are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Apr 2020 | ₹1.50 M | Open |
Andhra Bank Creation Date: 25 Jun 2014 | ₹1.50 Cr | Open |
Andhra Bank Creation Date: 25 Mar 2013 | ₹4.15 Cr | Open |
How Many Employees Work at Sri Padmavathi Breeding Farms?
Unlock and access historical data on people associated with Sri Padmavathi Breeding Farms, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Padmavathi Breeding Farms, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Padmavathi Breeding Farms's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
